2025 SCOPE Summit: Advancing Patient-Centric Clinical Trials
The 2025 SCOPE Summit brought together industry leaders to explore patient-centric approaches in clinical trials, addressing the critical issue...
Moe Alsumidaie
Medable’s France CNIL Regulatory Breakthrough: Pioneering Global Clinical Trials
Medable has achieved a significant milestone by securing regulatory approval from France’s CNIL, enhancing its global clinical trial capabilities....
Pragmatic Trials? All Talk, No Real Progress
Pragmatic clinical trials have become one of the industry’s favorite buzzwords, but where’s the real progress? Every year, the...
Revolutionizing Clinical Trials with AI and Decentralization
In the evolving world of clinical trials, AI and decentralization are key drivers of change. Iddo Peleg, CEO of...
Transforming Clinical Trials with AI: Insights from the Frontline
In the rapidly evolving landscape of clinical trials, technology is a game-changer. Dr. Michelle Papka, Ph.D., Founder and President...
Citeline’s Strategic Vision: Bridging Clinical Trials and Real-World Healthcare
In this discussion with Claire Riches, a veteran in clinical development, we explore Citeline’s strategic initiatives. As a leader...
Merck on Investigator-Initiated Studies and Budgeting Practices at 2025 SCOPE Summit
The 2025 SCOPE Summit’s panel discussion on investigator-initiated studies (IIS) delved into the complexities of budgeting practices, highlighting the...
2025 SCOPE Summit: Transforming Clinical Trials with Pragmatic Trial Approaches
The 2025 SCOPE Summit brought together industry leaders to explore integrating real-world data into clinical trials, focusing on pragmatic...
New Obesity Treatment Mechanisms: Dr. Bolz on Aphaia Pharma’s Innovative Approach
In this discussion with Steffen-Sebastian Bolz, MD, PhD, we explore Aphaia’s groundbreaking work in obesity treatment. With his dual...
Revolutionizing NSCLC Treatment: Insights from ImmunityBio’s CMO
In this discussion with Bobby Reddy, Chief Medical Officer of ImmunityBio, we delve into the innovative immunotherapy strategies targeting...